Increased arterial stiffness in resistant hypertension is associated with inflammatory biomarkers

Natália Ruggeri Barbaro1, Vanessa Fontana, Rodrigo Modolo

  • 1Laboratory of Cardiovascular Pharmacology, Faculty of Medical Sciences, University of Campinas (Unicamp) , Campinas , Brazil.

Blood Pressure
|July 26, 2014
PubMed

Insights

Resistant hypertension is linked to higher arterial stiffness and increased inflammatory markers like interleukin-1 beta (IL-1β). Elevated IL-1β levels independently predict arterial stiffness in these patients, suggesting inflammation

Area of Science:

  • Cardiovascular Medicine
  • Hypertension Research
  • Inflammation Biology

Background:

  • Hypertension is associated with increased inflammatory biomarkers, including IL-6, IL-10, IL-1β, TNF-α, and hs-CRP, contributing to arterial stiffness.
  • Resistant hypertension (RHTN) is linked to poor prognosis due to inadequate blood pressure control and target organ damage.
  • Inflammation is implicated in the pathophysiology of hypertension and its complications.

Purpose of the Study:

  • To evaluate the impact of inflammatory biomarkers on arterial stiffness in patients with resistant hypertension (RHTN).
  • To investigate the relationship between specific inflammatory cytokines and pulse wave velocity (PWV) in hypertensive individuals.

Main Methods:

  • A cross-sectional study involving 32 RHTN patients, 20 mild hypertensive (HTN) patients, and 20 normotensive (NT) controls.
  • Measurements included office blood pressure (BP), arterial stiffness assessed by pulse wave velocity (PWV), and plasma inflammatory biomarker levels.
  • Statistical analysis identified independent associations between biomarkers and PWV.

Main Results:

  • Pulse wave velocity (PWV) was significantly higher in RHTN patients compared to HTN and NT groups.
  • Tumor necrosis factor-alpha (TNF-α) levels were elevated in both RHTN and HTN patients versus NT.
  • Interleukin-1 beta (IL-1β) was independently associated with PWV (R² = 0.5, β = 0.077), and RHTN patients showed a higher frequency of elevated IL-10 and IL-1β.

Conclusions:

  • Resistant hypertension patients exhibit increased arterial stiffness and elevated levels of inflammatory cytokines, including TNF-α, IL-1β, and IL-10.
  • Interleukin-1 beta (IL-1β) levels are significantly associated with arterial stiffness in RHTN.
  • These findings suggest a potential role for inflammation in the development and progression of resistant hypertension.
Abstract

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.7K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
750
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
849
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.9K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.8K